PRD001 has passed the stage gate evaluation of “Strengthening Program for Pharmaceutical Startup Ecosystem” by AMED.
Our Lead project “PRD001” has passed the stage gate evaluation of “Strengthening Program for Pharmaceutical Startup Ecosystem” by AMED.
From the next stage, Taiho Innovations, our existing investor, also become follow-registered VC, and we receive additional funding from AMED.
With this support, we will advance global development of PRD001 with the aim of contributing to lipid metabolism disorder patients around the world.
More details here (Japanese only): 令和7年度「創薬ベンチャーエコシステム強化事業（創薬ベンチャー公募）」中間評価（ステージゲート評価）の結果について